reserpine has been researched along with rotenone in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Edwards, RH; Liu, Y; Roghani, A | 1 |
Danias, P; Mytilineou, C; Nicklas, WJ; Ofori, S; Shen, J | 1 |
Liu, HQ; Weng, EQ; Zhu, XZ | 1 |
Duenas, VJ; Garzon-Muvdi, T; Mahajan, R; Quiñones-Hinojosa, A; Shah, A | 1 |
1 review(s) available for reserpine and rotenone
Article | Year |
---|---|
Animal models of neurological disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Brain Ischemia; Central Nervous System; Central Nervous System Stimulants; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Neurotoxins; Oxidopamine; Reserpine; Rotenone; Uncoupling Agents | 2010 |
8 other study(ies) available for reserpine and rotenone
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Survival; CHO Cells; Cricetinae; Dopamine; Dose-Response Relationship, Drug; Drug Resistance; Kinetics; Oxidoreductases; Oxygen Consumption; PC12 Cells; Reserpine; Rotenone; Transfection | 1992 |
Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cells, Cultured; Designer Drugs; Dopamine; Embryo, Mammalian; Isoenzymes; Kinetics; Mazindol; Mesencephalon; Monoamine Oxidase; Neurons; Neurotoxins; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reserpine; Rotenone; Time Factors | 1989 |
Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Dopamine; L-Lactate Dehydrogenase; Lactic Acid; Monoamine Oxidase Inhibitors; Oxidation-Reduction; PC12 Cells; Rats; Reactive Oxygen Species; Reserpine; Rotenone; Selegiline | 2005 |